Can COVID-19 changes reduce stigma in African HIV clinics?
Sarah M Lofgren, Joanita Kigozi, Nakita G Natala, Sharon Tsui, Anita Arinda, Vanessa Akinyange, Raymond Sebuliba, David R Boulware, Barbara Castelnuovo
Article in The lancet. HIV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Sarah M LofgrenDivision of Infectious Diseases and Internal Medicine, University of Minnesota, Minneapolis, MN, USA. Electronic address: lofg0020@umn.edu.
Joanita KigoziInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Nakita G NatalaPsychiatry Department, University of Minnesota, Minneapolis, MN, USA.
Sharon TsuiKampala, Uganda.
Anita ArindaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Vanessa AkinyangeInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Raymond SebulibaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
David R BoulwareDivision of Infectious Diseases and Internal Medicine, University of Minnesota, Minneapolis, MN, USA.
Barbara CastelnuovoInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Funding
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.D43TW009771 · FIC · JOHNS HOPKINS UNIVERSITY · PI CASTELNUOVO, BARBARA, KAMBUGU, ANDREW DDUNGU · 2014 to 2023
$3.3M
Child Mental Health in HIV-impacted Low-Resource Settings in Developing Countries: Global Research FellowshipD43TW011541 · FIC · WASHINGTON UNIVERSITY · PI MCKAY, MARY MCKERNAN, NAKASUJJA, NOELINE · 2020 to 2024
$1.7M
Neuroinflammation and Modulating Factors in Depression and HIVK23MH121220 · NIMH · UNIVERSITY OF MINNESOTA · PI LOFGREN, SARAH · 2019 to 2022
$795k
Neurotrophic Factor Signaling in the Pathogenesis of HIV-associated Depression: Cohort and Mechanistic StudiesR21MH128839 · NIMH · UNIVERSITY OF MINNESOTA · PI LOFGREN, SARAH · 2021 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Can COVID-19 changes reduce stigma in African HIV clinics? · full record | OpenQuestion